Skip to content

Precigen PGEN Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
Gilead Sciences logo
Gilead SciencesGILD
$187.53B+19.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.86B+85.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$1.9B+15.2%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$5.84B+181%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's enterprise value?
Precigen (PGEN) reported enterprise value of $1.46B in Q1 2026.
How has Precigen's enterprise value changed year-over-year?
Precigen's enterprise value increased by 233.8% year-over-year, from $437.48M to $1.46B.
What is the long-term trend for Precigen's enterprise value?
Over 5 years (2020 to 2025), Precigen's enterprise value has grown at a -6.0% compound annual growth rate (CAGR), from $2.1B to $1.55B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.